+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Blood-Grouping Reagents Market 2024-2028

  • PDF Icon

    Report

  • 172 Pages
  • March 2024
  • Region: Global
  • TechNavio
  • ID: 4893961
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The blood-grouping reagents market is forecasted to grow by USD 520.68 mn during 2023-2028, accelerating at a CAGR of 8.13% during the forecast period. The report on the blood-grouping reagents market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of chronic disorders, rise in blood donations, and a growing number of hospitals and blood banks.

The blood-grouping reagents market is segmented as below:

By End-user

  • Hospitals and blood banks
  • Clinical laboratories
  • Academic and research institutes

By Technique

  • PCR-based and microarray techniques
  • Assay-based techniques
  • Massively parallel sequencing techniques
  • Serology

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the advancements in diagnostic devices as one of the prime reasons driving the blood-grouping reagents market growth during the next few years. Also, the growing adoption of multiplexing assays and integration of automation and high-throughput platforms in blood grouping will lead to sizable demand in the market.

The report on the blood-grouping reagents market covers the following areas:

  • Blood-grouping reagents market sizing
  • Blood-grouping reagents market forecast
  • Blood-grouping reagents market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading blood-grouping reagents market vendors that include AliveDX, Arena Bio Scien, ARKRAY Inc., Atlas Medical GmbH, BAG Health Care GmbH, Bio Rad Laboratories Inc., Calibre Scientific Inc., Danaher Corp., DIAGAST SAS, Grifols SA, Merck KGaA, Novacyt SA, QuidelOrtho Corp., Rapid Labs Ltd., Thermo Fisher Scientific Inc., Torax Biosciences Ltd., Tulip Diagnostics Pvt. Ltd., Fortress Diagnostics, Paragon Care Ltd., and VitroScient. Also, the blood-grouping reagents market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Technique
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global blood-grouping reagents market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global blood-grouping reagents market 2018 - 2022 ($ million)
4.2 End-User Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - End-User Segment 2018 - 2022 ($ million)
4.3 Technique Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Technique Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user
6.1 Market segments
Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
6.2 Comparison by End-user
Exhibit 32: Chart on Comparison by End-user
Exhibit 33: Data Table on Comparison by End-user
6.3 Hospitals and blood banks - Market size and forecast 2023-2028
Exhibit 34: Chart on Hospitals and blood banks - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Hospitals and blood banks - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Hospitals and blood banks - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Hospitals and blood banks - Year-over-year growth 2023-2028 (%)
6.4 Clinical laboratories - Market size and forecast 2023-2028
Exhibit 38: Chart on Clinical laboratories - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Clinical laboratories - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Clinical laboratories - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Clinical laboratories - Year-over-year growth 2023-2028 (%)
6.5 Academic and research institutes - Market size and forecast 2023-2028
Exhibit 42: Chart on Academic and research institutes - Market size and forecast 2023-2028 ($ million)
Exhibit 43: Data Table on Academic and research institutes - Market size and forecast 2023-2028 ($ million)
Exhibit 44: Chart on Academic and research institutes - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Academic and research institutes - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by End-user
Exhibit 46: Market opportunity by End-user ($ million)
Exhibit 47: Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Technique
7.1 Market segments
Exhibit 48: Chart on Technique - Market share 2023-2028 (%)
Exhibit 49: Data Table on Technique - Market share 2023-2028 (%)
7.2 Comparison by Technique
Exhibit 50: Chart on Comparison by Technique
Exhibit 51: Data Table on Comparison by Technique
7.3 PCR-based and microarray techniques - Market size and forecast 2023-2028
Exhibit 52: Chart on PCR-based and microarray techniques - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on PCR-based and microarray techniques - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on PCR-based and microarray techniques - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on PCR-based and microarray techniques - Year-over-year growth 2023-2028 (%)
7.4 Assay-based techniques - Market size and forecast 2023-2028
Exhibit 56: Chart on Assay-based techniques - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Assay-based techniques - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Assay-based techniques - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Assay-based techniques - Year-over-year growth 2023-2028 (%)
7.5 Massively parallel sequencing techniques - Market size and forecast 2023-2028
Exhibit 60: Chart on Massively parallel sequencing techniques - Market size and forecast 2023-2028 ($ million)
Exhibit 61: Data Table on Massively parallel sequencing techniques - Market size and forecast 2023-2028 ($ million)
Exhibit 62: Chart on Massively parallel sequencing techniques - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Massively parallel sequencing techniques - Year-over-year growth 2023-2028 (%)
7.6 Serology - Market size and forecast 2023-2028
Exhibit 64: Chart on Serology - Market size and forecast 2023-2028 ($ million)
Exhibit 65: Data Table on Serology - Market size and forecast 2023-2028 ($ million)
Exhibit 66: Chart on Serology - Year-over-year growth 2023-2028 (%)
Exhibit 67: Data Table on Serology - Year-over-year growth 2023-2028 (%)
7.7 Market opportunity by Technique
Exhibit 68: Market opportunity by Technique ($ million)
Exhibit 69: Data Table on Market opportunity by Technique ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 73: Chart on Geographic comparison
Exhibit 74: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 UK - Market size and forecast 2023-2028
Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.9 Canada - Market size and forecast 2023-2028
Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.10 France - Market size and forecast 2023-2028
Exhibit 103: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibit 104: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibit 105: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on France - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Exhibit 107: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 108: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 109: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 110: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 111: Market opportunity By Geographical Landscape ($ million)
Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 113: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 115: Overview on factors of disruption
11.4 Industry risks
Exhibit 116: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 117: Vendors covered
12.2 Market positioning of vendors
Exhibit 118: Matrix on vendor position and classification
12.3 AliveDX
Exhibit 119: AliveDX - Overview
Exhibit 120: AliveDX - Product / Service
Exhibit 121: AliveDX - Key offerings
12.4 Arena Bio Scien
Exhibit 122: Arena Bio Scien - Overview
Exhibit 123: Arena Bio Scien - Product / Service
Exhibit 124: Arena Bio Scien - Key offerings
12.5 ARKRAY Inc.
Exhibit 125: ARKRAY Inc. - Overview
Exhibit 126: ARKRAY Inc. - Product / Service
Exhibit 127: ARKRAY Inc. - Key offerings
12.6 Atlas Medical GmbH
Exhibit 128: Atlas Medical GmbH - Overview
Exhibit 129: Atlas Medical GmbH - Product / Service
Exhibit 130: Atlas Medical GmbH - Key offerings
12.7 Bio Rad Laboratories Inc.
Exhibit 131: Bio Rad Laboratories Inc. - Overview
Exhibit 132: Bio Rad Laboratories Inc. - Business segments
Exhibit 133: Bio Rad Laboratories Inc. - Key news
Exhibit 134: Bio Rad Laboratories Inc. - Key offerings
Exhibit 135: Bio Rad Laboratories Inc. - Segment focus
12.8 Calibre Scientific Inc.
Exhibit 136: Calibre Scientific Inc. - Overview
Exhibit 137: Calibre Scientific Inc. - Product / Service
Exhibit 138: Calibre Scientific Inc. - Key offerings
12.9 Danaher Corp.
Exhibit 139: Danaher Corp. - Overview
Exhibit 140: Danaher Corp. - Business segments
Exhibit 141: Danaher Corp. - Key news
Exhibit 142: Danaher Corp. - Key offerings
Exhibit 143: Danaher Corp. - Segment focus
12.10 DIAGAST SAS
Exhibit 144: DIAGAST SAS - Overview
Exhibit 145: DIAGAST SAS - Product / Service
Exhibit 146: DIAGAST SAS - Key offerings
12.11 Grifols SA
Exhibit 147: Grifols SA - Overview
Exhibit 148: Grifols SA - Business segments
Exhibit 149: Grifols SA - Key offerings
Exhibit 150: Grifols SA - Segment focus
12.12 Merck KGaA
Exhibit 151: Merck KGaA - Overview
Exhibit 152: Merck KGaA - Business segments
Exhibit 153: Merck KGaA - Key news
Exhibit 154: Merck KGaA - Key offerings
Exhibit 155: Merck KGaA - Segment focus
12.13 Novacyt SA
Exhibit 156: Novacyt SA - Overview
Exhibit 157: Novacyt SA - Business segments
Exhibit 158: Novacyt SA - Key offerings
Exhibit 159: Novacyt SA - Segment focus
12.14 Paragon Care Ltd.
Exhibit 160: Paragon Care Ltd. - Overview
Exhibit 161: Paragon Care Ltd. - Business segments
Exhibit 162: Paragon Care Ltd. - Key offerings
Exhibit 163: Paragon Care Ltd. - Segment focus
12.15 QuidelOrtho Corp.
Exhibit 164: QuidelOrtho Corp. - Overview
Exhibit 165: QuidelOrtho Corp. - Product / Service
Exhibit 166: QuidelOrtho Corp. - Key offerings
12.16 Thermo Fisher Scientific Inc.
Exhibit 167: Thermo Fisher Scientific Inc. - Overview
Exhibit 168: Thermo Fisher Scientific Inc. - Business segments
Exhibit 169: Thermo Fisher Scientific Inc. - Key news
Exhibit 170: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 171: Thermo Fisher Scientific Inc. - Segment focus
12.17 Tulip Diagnostics Pvt. Ltd.
Exhibit 172: Tulip Diagnostics Pvt. Ltd. - Overview
Exhibit 173: Tulip Diagnostics Pvt. Ltd. - Product / Service
Exhibit 174: Tulip Diagnostics Pvt. Ltd. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 175: Inclusions checklist
Exhibit 176: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 177: Currency conversion rates for US$
13.4 Research methodology
Exhibit 178: Research methodology
Exhibit 179: Validation techniques employed for market sizing
Exhibit 180: Information sources
13.5 List of abbreviations
Exhibit 181: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 6: Executive Summary - Chart on Market Segmentation by Technique
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global blood-grouping reagents market 2018 - 2022 ($ million)
Exhibits 19: Historic Market Size - End-User Segment 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - Technique Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on End-user - Market share 2023-2028 (%)
Exhibits 31: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by End-user
Exhibits 33: Data Table on Comparison by End-user
Exhibits 34: Chart on Hospitals and blood banks - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on Hospitals and blood banks - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on Hospitals and blood banks - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Hospitals and blood banks - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Clinical laboratories - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Clinical laboratories - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Clinical laboratories - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Clinical laboratories - Year-over-year growth 2023-2028 (%)
Exhibits 42: Chart on Academic and research institutes - Market size and forecast 2023-2028 ($ million)
Exhibits 43: Data Table on Academic and research institutes - Market size and forecast 2023-2028 ($ million)
Exhibits 44: Chart on Academic and research institutes - Year-over-year growth 2023-2028 (%)
Exhibits 45: Data Table on Academic and research institutes - Year-over-year growth 2023-2028 (%)
Exhibits 46: Market opportunity by End-user ($ million)
Exhibits 47: Data Table on Market opportunity by End-user ($ million)
Exhibits 48: Chart on Technique - Market share 2023-2028 (%)
Exhibits 49: Data Table on Technique - Market share 2023-2028 (%)
Exhibits 50: Chart on Comparison by Technique
Exhibits 51: Data Table on Comparison by Technique
Exhibits 52: Chart on PCR-based and microarray techniques - Market size and forecast 2023-2028 ($ million)
Exhibits 53: Data Table on PCR-based and microarray techniques - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Chart on PCR-based and microarray techniques - Year-over-year growth 2023-2028 (%)
Exhibits 55: Data Table on PCR-based and microarray techniques - Year-over-year growth 2023-2028 (%)
Exhibits 56: Chart on Assay-based techniques - Market size and forecast 2023-2028 ($ million)
Exhibits 57: Data Table on Assay-based techniques - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Chart on Assay-based techniques - Year-over-year growth 2023-2028 (%)
Exhibits 59: Data Table on Assay-based techniques - Year-over-year growth 2023-2028 (%)
Exhibits 60: Chart on Massively parallel sequencing techniques - Market size and forecast 2023-2028 ($ million)
Exhibits 61: Data Table on Massively parallel sequencing techniques - Market size and forecast 2023-2028 ($ million)
Exhibits 62: Chart on Massively parallel sequencing techniques - Year-over-year growth 2023-2028 (%)
Exhibits 63: Data Table on Massively parallel sequencing techniques - Year-over-year growth 2023-2028 (%)
Exhibits 64: Chart on Serology - Market size and forecast 2023-2028 ($ million)
Exhibits 65: Data Table on Serology - Market size and forecast 2023-2028 ($ million)
Exhibits 66: Chart on Serology - Year-over-year growth 2023-2028 (%)
Exhibits 67: Data Table on Serology - Year-over-year growth 2023-2028 (%)
Exhibits 68: Market opportunity by Technique ($ million)
Exhibits 69: Data Table on Market opportunity by Technique ($ million)
Exhibits 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 73: Chart on Geographic comparison
Exhibits 74: Data Table on Geographic comparison
Exhibits 75: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 76: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 77: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 92: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 93: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 99: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 100: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 103: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits 104: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits 105: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits 106: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits 107: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 108: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 109: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 110: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 111: Market opportunity By Geographical Landscape ($ million)
Exhibits 112: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 113: Impact of drivers and challenges in 2023 and 2028
Exhibits 114: Overview on Criticality of inputs and Factors of differentiation
Exhibits 115: Overview on factors of disruption
Exhibits 116: Impact of key risks on business
Exhibits 117: Vendors covered
Exhibits 118: Matrix on vendor position and classification
Exhibits 119: AliveDX - Overview
Exhibits 120: AliveDX - Product / Service
Exhibits 121: AliveDX - Key offerings
Exhibits 122: Arena Bio Scien - Overview
Exhibits 123: Arena Bio Scien - Product / Service
Exhibits 124: Arena Bio Scien - Key offerings
Exhibits 125: ARKRAY Inc. - Overview
Exhibits 126: ARKRAY Inc. - Product / Service
Exhibits 127: ARKRAY Inc. - Key offerings
Exhibits 128: Atlas Medical GmbH - Overview
Exhibits 129: Atlas Medical GmbH - Product / Service
Exhibits 130: Atlas Medical GmbH - Key offerings
Exhibits 131: Bio Rad Laboratories Inc. - Overview
Exhibits 132: Bio Rad Laboratories Inc. - Business segments
Exhibits 133: Bio Rad Laboratories Inc. - Key news
Exhibits 134: Bio Rad Laboratories Inc. - Key offerings
Exhibits 135: Bio Rad Laboratories Inc. - Segment focus
Exhibits 136: Calibre Scientific Inc. - Overview
Exhibits 137: Calibre Scientific Inc. - Product / Service
Exhibits 138: Calibre Scientific Inc. - Key offerings
Exhibits 139: Danaher Corp. - Overview
Exhibits 140: Danaher Corp. - Business segments
Exhibits 141: Danaher Corp. - Key news
Exhibits 142: Danaher Corp. - Key offerings
Exhibits 143: Danaher Corp. - Segment focus
Exhibits 144: DIAGAST SAS - Overview
Exhibits 145: DIAGAST SAS - Product / Service
Exhibits 146: DIAGAST SAS - Key offerings
Exhibits 147: Grifols SA - Overview
Exhibits 148: Grifols SA - Business segments
Exhibits 149: Grifols SA - Key offerings
Exhibits 150: Grifols SA - Segment focus
Exhibits 151: Merck KGaA - Overview
Exhibits 152: Merck KGaA - Business segments
Exhibits 153: Merck KGaA - Key news
Exhibits 154: Merck KGaA - Key offerings
Exhibits 155: Merck KGaA - Segment focus
Exhibits 156: Novacyt SA - Overview
Exhibits 157: Novacyt SA - Business segments
Exhibits 158: Novacyt SA - Key offerings
Exhibits 159: Novacyt SA - Segment focus
Exhibits 160: Paragon Care Ltd. - Overview
Exhibits 161: Paragon Care Ltd. - Business segments
Exhibits 162: Paragon Care Ltd. - Key offerings
Exhibits 163: Paragon Care Ltd. - Segment focus
Exhibits 164: QuidelOrtho Corp. - Overview
Exhibits 165: QuidelOrtho Corp. - Product / Service
Exhibits 166: QuidelOrtho Corp. - Key offerings
Exhibits 167: Thermo Fisher Scientific Inc. - Overview
Exhibits 168: Thermo Fisher Scientific Inc. - Business segments
Exhibits 169: Thermo Fisher Scientific Inc. - Key news
Exhibits 170: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 171: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 172: Tulip Diagnostics Pvt. Ltd. - Overview
Exhibits 173: Tulip Diagnostics Pvt. Ltd. - Product / Service
Exhibits 174: Tulip Diagnostics Pvt. Ltd. - Key offerings
Exhibits 175: Inclusions checklist
Exhibits 176: Exclusions checklist
Exhibits 177: Currency conversion rates for US$
Exhibits 178: Research methodology
Exhibits 179: Validation techniques employed for market sizing
Exhibits 180: Information sources
Exhibits 181: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global blood-grouping reagents market: AliveDX, Arena Bio Scien, ARKRAY Inc., Atlas Medical GmbH, BAG Health Care GmbH, Bio Rad Laboratories Inc., Calibre Scientific Inc., Danaher Corp., DIAGAST SAS, Grifols SA, Merck KGaA, Novacyt SA, QuidelOrtho Corp., Rapid Labs Ltd., Thermo Fisher Scientific Inc., Torax Biosciences Ltd., Tulip Diagnostics Pvt. Ltd., Fortress Diagnostics, Paragon Care Ltd., and VitroScient.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is advancements in diagnostic devices."

According to the report, one of the major drivers for this market is the increasing prevalence of chronic disorders.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AliveDX
  • Arena Bio Scien
  • ARKRAY Inc.
  • Atlas Medical GmbH
  • BAG Health Care GmbH
  • Bio Rad Laboratories Inc.
  • Calibre Scientific Inc.
  • Danaher Corp.
  • DIAGAST SAS
  • Grifols SA
  • Merck KGaA
  • Novacyt SA
  • QuidelOrtho Corp.
  • Rapid Labs Ltd.
  • Thermo Fisher Scientific Inc.
  • Torax Biosciences Ltd.
  • Tulip Diagnostics Pvt. Ltd.
  • Fortress Diagnostics
  • Paragon Care Ltd.
  • VitroScient